Hormonal Regulation and Hypertension Peer reviewed

Regression of Left Ventricular Hypertrophy in Primary Aldosteronism

Jessica Goi, Jacopo Burrello, Holger Schneider, Erik Petersenn and 28 more

Hypertension | Aug 17, 2026

Scollr summary

What this paper is about

LVH regressed in over half the patients after targeted treatment, with left ventricular mass index decreasing after both adrenalectomy and MRA therapy.

Full abstract

Read the full abstract

BACKGROUND: Left ventricular hypertrophy (LVH) is frequently identified in patients with primary aldosteronism; determinants of LVH regression after targeted treatment are debated. We assessed LVH prevalence before and after adrenalectomy or mineralocorticoid receptor antagonist (MRA) therapy, identified determinants of LVH regression, and evaluated the relationship between patients’ outcomes and cardiac remodeling. METHODS: We retrospectively analyzed an international cohort of patients with primary aldosteronism from 36 referral centers in Spain, Italy, and Germany. Echocardiographic recordings were included at baseline and after at least 1 year of targeted treatment. Regression models were applied to identify parameters associated with LVH regression and changes in left ventricular mass index. RESULTS: Among 1454 patients (mean age, 51 years; 58.7% male) with primary aldosteronism, baseline LVH prevalence was 49.4%. Aldosterone, blood pressure, male sex, number of antihypertensive medications, and diabetes were associated with LVH. Of 473 patients with a follow-up echocardiography, 33.6% underwent adrenalectomy, 61.7% received MRA, and 4.7% were taking MRA postsurgery. After a median follow-up of 51 months, LVH regression was observed in 54.2% of patients (61.9% after adrenalectomy versus 48.6% with MRA treatment; P =0.043), and left ventricular mass index significantly decreased after both surgery and medical therapy. Higher pretreatment blood pressure and aldosterone levels were associated with a lower likelihood of LVH regression, regardless of treatment modality. Complete biochemical success was associated with greater left ventricular mass index reduction at follow-up. CONCLUSIONS: LVH regressed in over half the patients after targeted treatment, with left ventricular mass index decreasing after both adrenalectomy and MRA therapy. Baseline aldosterone levels were associated with LVH regression, independently of blood pressure load.

Direct answer

What can I do from this paper page?

Use this page to scan "Regression of Left Ventricular Hypertrophy in Primary Aldosteronism" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Hormonal Regulation and Hypertension research, save the paper, or map adjacent work.

Authors

Researchers on this paper

Jessica Goi

first | Hospital Universitario Ramón y Cajal

Jacopo Burrello

middle | Department of Medical Sciences | ORCID 0000-0001-7884-7314

Holger Schneider

middle | LMU Klinikum | ORCID 0000-0003-1556-0951

Erik Petersenn

middle | LMU Klinikum | ORCID 0009-0008-1275-0585

Stephanie Zopp

middle | LMU Klinikum

Virginia Capuzzo

middle | Department of Medical Sciences

Ana María García Cano

middle | Hospital Universitario Ramón y Cajal | ORCID 0000-0002-2973-5436

Laura Caja Guayerbas

middle | Hospital Universitario Ramón y Cajal

Elena Mena Ribas

middle | Hospital Universitario Son Espases

Alicia Sanmartín Sánchez

middle | Hospital Universitario Son Espases | ORCID 0009-0000-0569-6842

Paola Parra Ramírez

middle | Hospital Universitario La Paz | ORCID 0000-0002-0310-7095

Patricia Martín Rojas‐Marcos

middle | Hospital Universitario La Paz | ORCID 0000-0002-3351-2868

Research areas

Follow related topics

Citation

BibTeX

@article{Goi2026Regression,
  title = {Regression of Left Ventricular Hypertrophy in Primary Aldosteronism},
  author = {Jessica Goi and Jacopo Burrello and Holger Schneider and Erik Petersenn and Stephanie Zopp and Virginia Capuzzo and Ana María García Cano and Laura Caja Guayerbas and Elena Mena Ribas and Alicia Sanmartín Sánchez and Paola Parra Ramírez and Patricia Martín Rojas‐Marcos and Miguel Paja and Patricia Díaz Guardiola and Ángel Rebollo Román and Eva María Moya Mateo and Jorge Gabriel Ruiz-Sánchez and Marga González Boillos and Fernando Jaén Águila and Carolina M. Perdomo and Cristina Robles Lázaro and Mònica Recasens and Rebeca Barahona San Millán and Emilia Gómez Hoyos and María José Picón César and Sonsoles Gutiérrez-Medina and Cristina Lamas and Anna Casteràs and Paolo Mulatero and Martín Reincke and Marta Araujo‐Castro and on behalf of the Adrenal Working Group of the Spanish Society of Endocrinology & Nutrition (SEEN)},
  journal = {Hypertension},
  year = {2026},
  doi = {10.1161/hypertensionaha.126.26909},
  url = {https://doi.org/10.1161/hypertensionaha.126.26909}
}

FAQ

Using this paper in a discovery workflow

How do I find related work for this paper?

Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.

How can I keep up with new Hormonal Regulation and Hypertension research papers?

Follow Hormonal Regulation and Hypertension research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.

Can I cite this paper from this page?

This page includes a static BibTeX block for Regression of Left Ventricular Hypertrophy in Primary Aldosteronism. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.

Follow this research in Scollr

Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.

Get the app